IgSF11 regulates osteoclast differentiation through association with the scaffold protein PSD-95

• Published in: Bone Research Vol. 8; no. 1; p. 5
• Main Authors: Kim, Hyunsoo, Takegahara, Noriko, Walsh, Matthew C., Middleton, Sarah A., Yu, Jiyeon, Shirakawa, Jumpei, Ueda, Jun, Fujihara, Yoshitaka, Ikawa, Masahito, Ishii, Masaru, Kim, Junhyong, Choi, Yongwon
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 10.02.2020; Springer Nature B.V
• Subjects: 631/443/63; 631/443/811; Internal Medicine; Medicine; Medicine & Public Health; Orthopedics; Proteins; Signal transduction; Bone quality and biomechanics; Bone
• ISSN: 2095-4700; 2095-6231
• DOI: 10.1038/s41413-019-0080-9

Osteoclasts are multinucleated, giant cells derived from myeloid progenitors. While receptor activator of NF-κB ligand (RANKL) stimulation is the primary driver of osteoclast differentiation, additional signaling further contributes to osteoclast maturation. Here, we demonstrate that immunoglobulin superfamily member 11 (IgSF11), whose expression increases during osteoclast differentiation, regulates osteoclast differentiation through interaction with postsynaptic density protein 95 (PSD-95), a scaffold protein with multiple protein interaction domains. IgSF11 deficiency in vivo results in impaired osteoclast differentiation and bone resorption but no observed defect in bone formation. Consequently, IgSF11-deficient mice exhibit increased bone mass. Using in vitro osteoclast culture systems, we show that IgSF11 functions through homophilic interactions. Additionally, we demonstrate that impaired osteoclast differentiation in IgSF11-deficient cells is rescued by full-length IgSF11 and that the IgSF11-PSD-95 interaction requires the 75 C-terminal amino acids of IgSF11. Our findings reveal a critical role for IgSF11 during osteoclast differentiation and suggest a role for IgSF11 in a receptor- and signal transduction molecule-containing protein complex.